Resolute Bio has raised €10M in seed funding to advance ResOne, its spatial proteomics platform for molecular intelligence.
Led by CEO Ishani Ummat, with co-founders including @MundAndreas, the company combines mass spectrometry and digital pathology to uncover disease biology, biomarkers, and therapeutic targets.
resolute.bio/insights/spatia…
Subscribe to our newsletter and get the biggest biotech news straight to your inbox 🧬syntheticbiologysummit.com/2…
Check out the new @Nature feature on Deep Visual Proteomics's use of AI, imaging, laser microdissection & mass spectrometry for advanced molecular profiling. Matthias highlights its potential for precision medicine & deeper understanding of diseases. #DVPbit.ly/3TF9VgV